Cargando…

RNA 2′-O-methylation modification and its implication in COVID-19 immunity

Detalles Bibliográficos
Autor principal:	Paramasivam, Arumugam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648894/ https://www.ncbi.nlm.nih.gov/pubmed/33298836 http://dx.doi.org/10.1038/s41420-020-00358-z

Ejemplares similares

Implication of epitranscriptomics in trained innate immunity and COVID-19
por: Arumugam, Paramasivam, et al.
Publicado: (2021)

COVID-19: immunopathology and its implications for therapy
por: Cao, Xuetao
Publicado: (2020)

Covid-19 and its impact on immunization programs: reflections from Brazil
por: Matos, Camila Carvalho de Souza Amorim, et al.
Publicado: (2020)

COVID-19: implications for immunosuppression in kidney disease and transplantation
por: Kronbichler, Andreas, et al.
Publicado: (2020)

Implications of COVID-19 sequelae for health-care personnel
por: Praschan, Nathan, et al.
Publicado: (2021)

Immunomodulatory and immunosuppressive medication modification among patients with rheumatic diseases at the time of COVID-19 vaccination
por: Barbhaiya, Medha, et al.
Publicado: (2022)

Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors
por: Waissengrin, Barliz, et al.
Publicado: (2021)

COVID-19 and endoscopy: implications for healthcare and digestive cancer screening
por: Gralnek, Ian M., et al.
Publicado: (2020)

Implications of COVID-19 for patients with pre-existing digestive diseases
por: Mao, Ren, et al.
Publicado: (2020)

The type I interferon response in COVID-19: implications for treatment
por: Lee, Jeong Seok, et al.
Publicado: (2020)

Nebulised heparin for patients on ventilation: implications for COVID-19 pneumonia
por: Ball, Lorenzo, et al.
Publicado: (2021)

Implications of COVID-19 vaccine effectiveness waning for public health
por: Odone, Anna, et al.
Publicado: (2022)

The lapse of federal COVID-19 funding: implications for health equity
por: Kobayashi, Kelsen, et al.
Publicado: (2023)

Waning immunity to SARS-CoV-2: implications for vaccine booster strategies
por: Altmann, Daniel M, et al.
Publicado: (2021)

Humoral and cellular immune responses to mRNA COVID-19 vaccines in patients with axial spondyloarthritis treated with adalimumab or secukinumab
por: Smetanova, Jitka, et al.
Publicado: (2022)

COVID-19 herd immunity: where are we?
por: Fontanet, Arnaud, et al.
Publicado: (2020)

The elusive goal of COVID-19 vaccine immunity
por: Abu-Raddad, Laith J, et al.
Publicado: (2023)

Hybrid immunity and strategies for COVID-19 vaccination
por: Hui, David S
Publicado: (2023)

Targeting METTL14 and RNA methylation to treat osteosarcoma
por: Ren, Lili, et al.
Publicado: (2022)

Implications of COVID-19 for uveitis patients: perspectives from Hong Kong
por: Hung, Jennifer C. H., et al.
Publicado: (2020)

Implications of COVID-19 for patients with pre-existing digestive diseases: an update
por: Mao, Ren, et al.
Publicado: (2021)

Severe breakthrough COVID-19 infections in Scotland—implications for immunisation programmes
por: Leshem, Eyal, et al.
Publicado: (2021)

COVID-19 infection: mitohormetic concept of immune response
por: Gebicki, Jerzy, et al.
Publicado: (2020)

COVID-19 herd immunity by immunisation: are children in the herd?
por: Obaro, Stephen
Publicado: (2021)

Genomics in the era of COVID-19: ethical implications for clinical practice and public health
por: Geller, Gail, et al.
Publicado: (2020)

Loss of CpG island immunity to DNA methylation induced by mutation
por: Horsthemke, Bernhard, et al.
Publicado: (2023)

An encounter with the mild side of LARS2-associated Perrault syndrome and its implications on the diagnostic odyssey
por: Vona, Barbara
Publicado: (2023)

COVID-19 mRNA vaccination and myocarditis or pericarditis
por: Husby, Anders, et al.
Publicado: (2022)

COVID-19 vaccine design: the Janus face of immune enhancement
por: Hotez, Peter J., et al.
Publicado: (2020)

COVID-19 vaccines: modes of immune activation and future challenges
por: Teijaro, John R., et al.
Publicado: (2021)

Immunity after COVID-19 vaccinations in immunocompromised patients with psoriasis
por: Boekel, Laura
Publicado: (2022)

COVID-19 vaccination in patients with immunity-mediated kidney disease
por: Prendecki, Maria, et al.
Publicado: (2021)

Effectiveness of COVID-19 vaccination in immune-mediated inflammatory diseases
por: Sparks, Jeffrey A, et al.
Publicado: (2022)

Considerations of hybrid immunity and the future of adolescent COVID-19 vaccination
por: Irving, Stephanie A, et al.
Publicado: (2023)

COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study
por: Ferri, Clodoveo, et al.
Publicado: (2021)

Antifungal immune responses: emerging host–pathogen interactions and translational implications
por: Kumar, Vinod, et al.
Publicado: (2018)

Safety of mRNA COVID-19 vaccines during pregnancy
por: Ellington, Sascha, et al.
Publicado: (2022)

Unintended consequences of restrictive visitation policies during the COVID-19 pandemic: implications for hospitalized children
por: Raphael, Jean L., et al.
Publicado: (2021)

Strategies to minimize inequity in COVID-19 vaccine access in the US: Implications for future vaccine rollouts
por: Chhibber, Anindit, et al.
Publicado: (2021)

Health and economic implications of the ongoing coronavirus disease (COVID-19) pandemic on women and children in Africa
por: Yeboah, Helena, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5rffr1pr8qjigraqcthoafl5ed